<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02464592</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-CRI-2014-05</org_study_id>
    <nct_id>NCT02464592</nct_id>
  </id_info>
  <brief_title>Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. A Multicenter Study</brief_title>
  <official_title>Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. A Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario La Fe</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Germans Trias i Pujol Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital General Universitario Santa Lucía</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitari de Bellvitge</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Complexo Hospitalario Universitario de Vigo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Complejo Asistencial Universitario de Salamanca</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario de Valladolid</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the diagnostic yield and safety of transbronchial
      lung biopsies (TBLB) with cryoprobe versus conventional forceps in patients with diffuse lung
      disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2014</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic yield of transbronchial lung biopsy (TBLB)</measure>
    <time_frame>24 months</time_frame>
    <description>Comparing those TBLB obtained by cryoprobes versus conventional forceps (number of diagnosis with each technique).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Histological quality of samples as defined the presence of alveolar units in each sample. Composite measure.</measure>
    <time_frame>24 months</time_frame>
    <description>The quality of samples are defined by the size, presence of artifacts and presence of alveolar units in each sample.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety related to the procedure of the TBLB obtained by cryoprobe compared with conventional forceps assessed by chest radiography.</measure>
    <time_frame>24 months</time_frame>
    <description>Chest radiography after TBLB.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety related to the procedure of the TBLB obtained by cryoprobe compared with conventional forceps assessed by control of bleeding.</measure>
    <time_frame>24 months</time_frame>
    <description>Control of bleeding during procedure.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Lung Diseases, Interstitial</condition>
  <arm_group>
    <arm_group_label>Biopsy with Cryoprobes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transbronchial lung biopsy with a cryoprobe.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biopsy with Conventional Forceps</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transbronchial lung biopsy with conventional forceps.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transbronchial lung biopsy.</intervention_name>
    <description>Transbronchial lung biopsy with cryoprobe and with conventional forceps.</description>
    <arm_group_label>Biopsy with Cryoprobes</arm_group_label>
    <arm_group_label>Biopsy with Conventional Forceps</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 years old

          -  Patients with diffuse lung disease candidate to study with transbronchial lung biopsy
             (TBLB).

          -  Inform consent signed.

        Exclusion Criteria:

          -  FEV1 &lt;40% of reference value.

          -  Respiratory insufficiency (pO2 &lt;60 mmHg or pCO2 &gt;45 mmHg).

          -  Use of anticoagulant therapy or presence of a coagulation (disorder abnormal platelets
             counts, international normalized ratio &gt; 1.5).

          -  Bullous emphysema.

          -  Pulmonary arterial hypertension.

          -  Hypersensitivity to anaesthetic and sedative drugs (lidocaine, midazolam, propofol,
             remifentanyl).

          -  Psychiatric illness.

          -  Comorbidities that could increase the risk of the TBLB.

          -  Pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Virginia Pajares, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Pajares V, Puzo C, Castillo D, Lerma E, Montero MA, Ramos-Barbón D, Amor-Carro O, Gil de Bernabé A, Franquet T, Plaza V, Hetzel J, Sanchis J, Torrego A. Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial. Respirology. 2014 Aug;19(6):900-6. doi: 10.1111/resp.12322. Epub 2014 Jun 1.</citation>
    <PMID>24890124</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2015</study_first_submitted>
  <study_first_submitted_qc>June 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2015</study_first_posted>
  <last_update_submitted>September 27, 2017</last_update_submitted>
  <last_update_submitted_qc>September 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cryoprobes</keyword>
  <keyword>Transbronchial lung biopsy</keyword>
  <keyword>Cryobiopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

